No abstract available
MeSH terms
-
Adult
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Child
-
Daclizumab
-
Female
-
Follow-Up Studies
-
Graft Rejection / immunology*
-
Graft Rejection / prevention & control
-
Graft Survival*
-
Histocompatibility Testing*
-
Humans
-
Immunoglobulin G / therapeutic use
-
Immunosuppressive Agents / therapeutic use
-
Intestines / transplantation*
-
Male
-
Muromonab-CD3 / therapeutic use
-
Postoperative Complications / classification
-
Postoperative Complications / epidemiology
-
Retrospective Studies
-
Survival Rate
-
T-Lymphocytes, Cytotoxic / immunology*
-
Time Factors
-
Transplantation, Homologous / immunology*
-
Transplantation, Homologous / mortality
-
Transplantation, Homologous / physiology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Immunosuppressive Agents
-
Muromonab-CD3
-
Daclizumab